Anti-BCMA CAR T Cells

Overview

Anti-BCMA CAR T Cells are a BCMA targeted CAR T Cell therapy being developed at the National Cancer Institute.

SparkCures ID	127
Generic Name	Anti-BCMA CAR T Cells
Treatment Classifications	Adoptive Cellular Therapy CAR T Cell T Cell Engager (TCE)
Treatment Targets	B-Cell Maturation Antigen (BCMA)

All Clinical Trials

View all active clinical trials around the US.

CRISPR DELIVERED ANTI-BCMA CAR-T

View Trial

Multiple Myeloma

No active clinical trials

Smoldering Myeloma

No active clinical trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

No active clinical trials

There are no resources, links or videos to display for this treatment.